Leader
Do patients with osteoarthritis get the clinical research they need?
| The first 150 words of the full text of this article appear below. |
| |
Article |
|---|
The most obvious and laudable reason for doing clinical
research is, of course, to benefit the patients. Other motives that are
sometimes important are to earn money, to increase chances of getting
the next post, to become famous, or to satisfy curiosity. Such
incentives are not necessarily bad. Indeed, the high level of
competition in healthcare research may very well be more innovative and
productive
and therefore more beneficial to the patients
than more
centralised research approaches.
A particular piece of research may occasionally fulfil all five
motives, but it would be the exception rather than the rule if research
agendas overall matched even remotely what the patients need most. For
example, according to the WHO, the combined investment in research and
development into acute respiratory infections, diarrhoeal diseases, and
tuberculosis
which kill over seven million people a year
amounts to
0.2% of global spending on health research and development,
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
